Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4518 USD | +9.93% |
|
-5.48% | -30.49% |
May. 13 | Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 25 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.49% | 1.96M | |
+48.75% | 57.87B | |
+41.65% | 40.25B | |
-7.35% | 39.94B | |
-5.96% | 28.54B | |
+12.34% | 26.4B | |
-20.17% | 19.33B | |
+30.22% | 12.4B | |
-0.64% | 12.23B | |
+24.64% | 12.2B |
- Stock Market
- Equities
- SLRX Stock
- News Salarius Pharmaceuticals, Inc.
- HC Wainwright Adjusts Salarius Pharmaceuticals' Price Target to $4 From $5, Reiterates Buy Rating